Journal
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
Volume 12, Issue 8, Pages 2311-2320Publisher
ELSEVIER
DOI: 10.1016/j.nano.2016.06.009
Keywords
Oxidative stress; Cerium oxide nanoparticles; Amyotrophic lateral sclerosis
Funding
- Cerion Nrx
Ask authors/readers for more resources
Cerium oxide nanoparticles (CeNPs) neutralize reactive oxygen and nitrogen species. Since oxidative stress plays a role in amyotrophic lateral sclerosis (ALS) in humans and in the SOD1(G93A) mouse model of ALS, we tested whether administration of CeNPs would improve survival and reduce disease severity in SOD1(G93A) transgenic mice. Twice a week intravenous treatment of SOD1(G93A) mice with CeNPs started at the onset of muscle weakness preserved muscle function and increased longevity in males and females. Median survival after the onset of CeNP treatment was 33.0 +/- 3.7 days (N = 20), and only 22.0 +/- 2.5 days in mice treated with vehicle, control injections (N = 27; P = 0.022). Since these citrate-EDTA stabilized CeNPs exhibited catalase and oxidase activity in cell-free systems and in in vitro models of ischemic oxidative stress, we hypothesize that antioxidant activity is the protective mechanism prolonging survival in the SOD1(G93A) mice. (C) 2016 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available